Raghu Kalluri

45PUBLICATIONS
191CO-AUTHORS
Molecular targetsAerodynamics (excl. hypersonic aerodynamics)Genomics and transcriptomicsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 26, 2026
Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer.

|Jul 11, 2026
CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC.

|Jul 10, 2026
Advancements in extracellular vesicle research.

|Nov 27, 2025
scPER: A Rigorous Computational Approach to Determine Cellular Subtypes in Tumors Aligned With Cancer Phenotypes From Total RNA Sequencing.

Bingrui Li, Xiaobo Zhou, Raghu Kalluri

|Sep 30, 2025
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates.

Valerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan

|Sep 09, 2025
Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer.

Taslim A Al-Hilal, Maria-Anna Chrysovergi, Paula E Grasberger

Pageof 8

Frequent Collaborators

18 joint publications

Kathleen M McAndrews

7 joint publications

Valerie S LeBleu

5 joint publications

Krishnan K Mahadevan

4 joint publications

Yang Chen